Related Topics News - Drugs

     
 < Previous page   Title only   |   Print    Next page > 
     
中生製藥TQH5528於ERS 2026公布臨床前研究數據

2026-09-08T  
諾和諾德:後期試驗顯示司美格魯肽可改善兒童肥胖率

2026-09-08T  
石藥啟動SYH2085片治療成人單純性流感II期內地臨床

2026-09-08T  
聯邦制藥UBT251注射液完成中國2型糖尿病III期臨床首例給藥

2026-09-08T  
《大行》瑞銀降聯邦制藥目標價至12.8元 上半年純利符預期評級「買入」

2026-09-07T  
聯邦制藥UBT251注射液完成中國超重/肥胖III期臨床首例給藥

2026-09-07T  
中生製藥GPC3 ADC臨床試驗申請獲FDA批准

2026-09-04T  
《新股》金斯瑞生物擬分拆蓬勃生物於主板上市

2026-09-04T  
康哲藥業創新藥百盧妥在中國獲批增加特應性皮炎適應症上市許可

2026-09-03T  
軒竹生物與INNOBIC就吡洛西利泰國市場達商業化合作

2026-09-03T  
 < Previous page    Next page > 

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2026 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.